Core Viewpoint - Lifeway Foods remains focused on enhancing shareholder value following Danone's withdrawal of its acquisition proposal, emphasizing the execution of its strategic growth plan [1][2]. Financial Performance - Lifeway achieved record net sales of $53.9 million in Q2 2025, marking an 18% year-over-year increase on a comparable basis [6]. - In the first two months of Q3 2025, Lifeway recorded $39.1 million in unaudited net sales, representing a 20% year-over-year increase [6]. - The company has maintained a track record of 22 consecutive quarters of growth, solidifying its position as a retail dairy innovator [6]. Strategic Initiatives - A Strategic Review Committee has been formed, consisting solely of independent directors, to oversee the exploration of opportunities to maximize shareholder value [2]. - Lifeway is committed to executing its growth strategy and exploring value-enhancing opportunities for shareholders, employees, partners, and customers [1][2]. Company Overview - Lifeway Foods is recognized as a leading supplier of kefir and fermented probiotic products in the U.S., with a diverse product line that includes drinkable kefir and a ProBugs® line for children [4]. - The company's products are distributed across multiple countries, including the U.S., Mexico, Ireland, South Africa, the UAE, and France [4].